Navigation Links
First Paralyzed Formula Race Car Driver's "Road to Indy" Sponsored By Coloplast
Date:5/15/2012

MINNEAPOLIS, May 15, 2012 /PRNewswire/ -- Coloplast North America, a provider of products and services for people with intimate medical needs, has announced a corporate sponsorship of Michael Johnson, formula racing's first paralyzed driver.

Johnson, 19, is competing this year in The Cooper Tires USF2000 Championship Powered by Mazda, the first step on the Road to Indy, an open-wheeled development program for drivers seeking a professional racing career. Johnson's goal is to be the first paralyzed driver to compete in the Indy500.

With modifications to his car and the use of medical devices, Johnson is able to compete at the professional level. One of those devices is Coloplast's SpeediCath® coated catheter providing hygienic, convenient catheterization.

"Coloplast's mission is to improve patient quality of life. Michael Johnson embodies that mission. He is redefining the sport and erasing boundaries, proving that with the right mix of innovation and passion, any obstacle can be overcome," said Tom Remmel, SpeediCath Product Manager. "We are proud to be part of this racing team and will be cheering for Michael every step of the way, especially when he crosses the finish line at Indy500 for the first time."

Coloplast's sponsorship provides financial support for Michael Johnson racing. Coloplast and SpeediCath logos will be displayed on Johnson's car and gear throughout the season.

"I sincerely appreciate Coloplast's support in pursuing my dream," Johnson said. "Their sponsorship fuels my team's aim to advance to the IndyCar series, and SpeediCath gives me the convenience and freedom to focus on my training."

A Lifelong Desire For Competition

In 2005, Johnson was a 14-time motorcycle-racing champion. He became paralyzed from mid-chest down after spinal cord injuries suffered in a dirt-track competition.

Despite having no feeling in his legs, Johnson never gave up his desire to race competitively. His experience using his hands to apply throttle, brake and clutch in motorcycle racing paid off in the years following his paralyzing accident. He racked up numerous wins in go-kart competitions, driving specially-designed vehicles with hand controls instead of foot pedals.

Johnson's adult stem cell surgery in 2009, followed by aggressive physical therapy, stimulated some sensation, and gave Johnson the confidence to race formula cars professionally on tracks throughout the U.S. this year.

"My goal is to become the first paralyzed driver to win the Indy500," Johnson said. "My journey may seem unconventional, but we all have different paths to reach our potential and live life to the fullest. I might have some challenges here or there but I'm never going to give up. Racing is my life."

Learn more at www.MichaelJohnsonRacing.com or through this video.

About Coloplast.

Coloplast's business includes ostomy, urology, continence, and wound and skin care. Coloplast operates globally and employs more than 7,500 people worldwide. In 2009, Coloplast opened its North American headquarters in Minneapolis, Minnesota. The campus is LEED-certified and is home to one of the company's three global research-and-development Innovation Centers. www.us.coloplast.com.


'/>"/>
SOURCE Coloplast
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Pressure BioSciences, Inc. to Discuss First Quarter 2012 Financial Results And Provide Business Update
2. PLC Systems Reports First Quarter 2012 Results
3. PGI Reports First Quarter 2012 Results
4. Medical Marijuana, Inc. Announces First Quarter 2012 Results
5. BiO2 Medical Granted CE Mark for the Angel™ Catheter, the First IVC Filter with a Prophylactic Use Indication
6. InfuSystem Holdings, Inc. To Announce First Quarter 2012 Financial Results On May 21, 2012
7. GeoVax Labs Reports 2012 First Quarter Financial Results
8. Pernix Therapeutics Introduces Omeclamox-Pak®, First Product in Gastroenterology Portfolio
9. Novelos Therapeutics Successfully Completes First Cohort In Phase 1b Solid Tumor Trial With I-131-CLR1404 (HOT) Cancer-Targeted Molecular Radiotherapeutic
10. EntreMed Reports First Quarter 2012 Financial Results
11. China Pharma Holdings, Inc. Reports First Quarter 2012 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... -- Urologix, the market leader for in-office minimally invasive ... (BPH), announces new private ownership and is operating as ... industry veteran of more than 20 years, has been ... Plymouth, Minn. The company,s two ... RF Therapy, will continue to be broadly available and ...
(Date:2/10/2016)... Feb. 10, 2016  Rich Pharmaceuticals, Inc. (OTC Markets: ... 1-for-100 reverse split of its issued and outstanding shares ... on Thursday, February 11, 2016. The Company,s common stock ... number 76303T308 and temporary ticker symbol "RCHAD". After 20 ... the ticker symbol (RCHA).  --> ...
(Date:2/10/2016)... 10, 2016  Oxis International Inc. (OTC/QB: OXIS) announced ... described as a "clinical trial triumph" after one of ... complete cancer remission. Daniel Vallera , ... Cancer Center. --> Daniel Vallera , ... Cancer Center. --> An article on ...
Breaking Medicine Technology:
(Date:2/10/2016)... (PRWEB) , ... February 10, 2016 , ... ... working together to expand dental health services to the developmentally disabled in the ... Care Dental’s operations to a new facility at 71-949 Highway 111, Suite 100-B, ...
(Date:2/10/2016)... ... February 10, 2016 , ... InDemand Interpreting , ... recently partnered with Heart City Health Center to improve access to ... Heart City Health Center has provided the Elkhart community with access to high ...
(Date:2/10/2016)... ... February 10, 2016 , ... ... charity program created to assist the local community. Pledging to select a new ... nonprofit organizations in the area. Their goal is to bring community awareness to ...
(Date:2/10/2016)... ... February 10, 2016 , ... Dr. ... office is now offering a variety of comprehensive procedures for facial enhancement. The ... facial volume restoration, lip enhancement and nasal reshaping. , As a result, ...
(Date:2/10/2016)... ... February 10, 2016 , ... Intalere’s 2016 Executive Forum, ... 200 of the country’s top healthcare executives to share insights on transformational strategies ... the Forum is the provider-centric perspective, experience, expertise and strategy shared by the ...
Breaking Medicine News(10 mins):